| Name | Title | Contact Details |
|---|
NeurogesX, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Foster City, CA. To find more information about NeurogesX, Inc., please visit www.neurogesx.com
Sawtooth Surgery Center is a Twin Falls, ID-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ortho Kinematics is committed to the idea that spine motion matters.
Designated “Best of Nursing Homes 2019-2020 - Highest Performing Short-Term Stay” by U.S. News and World Report (Bloomingdale, Chicago Ridge, Elmhurst, La Grange, Lake Zurich, Lombard, Schaumburg) Designated “Best of Nursing Homes 2020” by Newsweek (Bloomingdale) Winner of McKnight`s Long-Term Care News Excellence in Technology "2017 Gold Innovator of the Year" for Curatess Telemedicine Platform Awarded "Best"/Top Performer by U.S. News and World Report: Lexington Health Care Center of Elmhurst Lexington Health Network is Chicagoland`s premier provider of post-acute care & rehabilitation, long-term care, memory care, independent & assisted living, home health care, hospice care and private duty nursing. As the leader of integrated health services, Lexington Health Network is with you, from hospital to home and beyond. Today, Lexington Health Network manages more than 2,000 skilled nursing beds in 10 different post hospital, nursing and long term care buildings as well as more than 500 independent retirement units and more than 150 assisted living units within 3 senior living centers. Our diverse network of health care services also offers home health care, hospice care and private care services. Lexington proudly employs more than 2,500 full and part time individuals enabling us to provide an immeasurable value to the communities we serve. So much of who we are comes from an integrated organization dedicated to the highest attainable quality of care available today. As a family-owned organization, we have always maintained a unique perspective. Whether you are a post-acute patient, resident, a family member, or an employee, you are considered an extension of our family. In an industry filled with rapid change and growth, the Lexington constant, of our commitment to family values, will never change. Welcome to the Lexington Health Network.
ContraVir is a biopharmaceutical company focused primarily on the development of drugs to treat herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus or VZV. Our lead candidate, FV-100, is an orally available nucleoside analogue prodrug of CF-1743 that we are developing for the treatment of shingles. Published preclinical studies demonstrate that FV-100 is significantly more potent against VZV than acyclovir, valacyclovir, and famciclovir, the FDA-approved drugs used for the treatment of shingles. Preclinical studies further demonstrate that FV-100 has a more rapid onset of antiviral activity, and may fully inhibit the replication of VZV more rapidly than these drugs at significantly lower concentration levels. In addition, pharmacokinetic data from completed phase 1 and 2 clinical trials suggest that FV-100 has the potential to demonstrate antiviral activity when dosed orally once-a-day at significantly lower levels than valacyclovir, acyclovir, and famciclovir.